The Anglo-American life sciences VC firm has exceeded the original $275m target for their Abingworth Bioventures IV fund (ABV IV), which was more than two times over-susbscribed.
The European Bank for Reconstruction and Development has made a E15m commitment to Euroventures Hungary III, the latest fund to target one of the EU accession states.
The UK-based mid-market buyout firm has secured E50m of commitments for its second fund including a E10m investment from Inflexion Plc.
Delegates in London at the Private Equity COO & CFO Forum have revealed that relations with their limited partners have taken a darker turn.
London-based mid-market buyout firm Cabot Square Capital has closed its second fund above target at E284m.
The Swiss-based private equity group is among a group of international investors in Arsenal Capital Partners' debut $300m mid-market buyout fund.
The Swedish private equity firm has fallen short of its original E300m target for the Procuritas Capital Investors III fund launched in 2001.
The insurer's private equity investment arm says it is on course for a final close on E250m in July 2003.
Schroder Ventures Life Sciences, which closed $2m above its original target, received commitments from 18 institutions that backed the firm for the first time.
Nineteen Finnish institutions have committed to the fund, which will invest in management buyouts across the Nordic region.